![HIV protease inhibitors and onset of cardiovascular diseases: A central role for oxidative stress and dysregulation of the ubiquitin–proteasome system - ScienceDirect HIV protease inhibitors and onset of cardiovascular diseases: A central role for oxidative stress and dysregulation of the ubiquitin–proteasome system - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S092544391300344X-gr1.jpg)
HIV protease inhibitors and onset of cardiovascular diseases: A central role for oxidative stress and dysregulation of the ubiquitin–proteasome system - ScienceDirect
![Remdesivir and its antiviral activity against COVID-19: A systematic review - Clinical Epidemiology and Global Health Remdesivir and its antiviral activity against COVID-19: A systematic review - Clinical Epidemiology and Global Health](https://cegh.net/cms/asset/c844522c-cc96-4e8d-b195-26f5d80c9861/gr1.jpg)
Remdesivir and its antiviral activity against COVID-19: A systematic review - Clinical Epidemiology and Global Health
![Research Highlight: Derivatization and Combination Therapy of COVID-19 Therapeutic agents | LAU News Research Highlight: Derivatization and Combination Therapy of COVID-19 Therapeutic agents | LAU News](https://news.lau.edu.lb/images/covid-research-2020-01.jpg)
Research Highlight: Derivatization and Combination Therapy of COVID-19 Therapeutic agents | LAU News
![Why Are Lopinavir and Ritonavir Effective against the Newly Emerged Coronavirus 2019? Atomistic Insights into the Inhibitory Mechanisms | Biochemistry Why Are Lopinavir and Ritonavir Effective against the Newly Emerged Coronavirus 2019? Atomistic Insights into the Inhibitory Mechanisms | Biochemistry](https://pubs.acs.org/cms/10.1021/acs.biochem.0c00160/asset/images/large/bi0c00160_0003.jpeg)
Why Are Lopinavir and Ritonavir Effective against the Newly Emerged Coronavirus 2019? Atomistic Insights into the Inhibitory Mechanisms | Biochemistry
![Core Concepts - Antiretroviral Medications and Initial Therapy - Antiretroviral Therapy - National HIV Curriculum Core Concepts - Antiretroviral Medications and Initial Therapy - Antiretroviral Therapy - National HIV Curriculum](https://cdn.hiv.uw.edu/doc/942-1/mechanism-action-attachment-inhibitors.jpg)
Core Concepts - Antiretroviral Medications and Initial Therapy - Antiretroviral Therapy - National HIV Curriculum
Approaches to the Potential Therapy of COVID-19: A General Overview from the Medicinal Chemistry Perspective
![Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2 - ScienceDirect Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2 - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0753332220308611-gr1.jpg)
Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2 - ScienceDirect
![Epidemic and pandemic viral infections: impact on tuberculosis and the lung | European Respiratory Society Epidemic and pandemic viral infections: impact on tuberculosis and the lung | European Respiratory Society](https://erj.ersjournals.com/content/erj/56/4/2001727/F2.large.jpg)
Epidemic and pandemic viral infections: impact on tuberculosis and the lung | European Respiratory Society
![Frontiers | Mechanism of Action of Small-Molecule Agents in Ongoing Clinical Trials for SARS-CoV-2: A Review Frontiers | Mechanism of Action of Small-Molecule Agents in Ongoing Clinical Trials for SARS-CoV-2: A Review](https://www.frontiersin.org/files/Articles/840639/fphar-13-840639-HTML-r1/image_m/fphar-13-840639-g001.jpg)
Frontiers | Mechanism of Action of Small-Molecule Agents in Ongoing Clinical Trials for SARS-CoV-2: A Review
![Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet](https://www.thelancet.com/cms/attachment/b9733e70-68a2-473a-8618-32f0f5a0590c/gr1_lrg.gif)
Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet
Why Are Lopinavir and Ritonavir Effective against the Newly Emerged Coronavirus 2019? Atomistic Insights into the Inhibitory Mechanisms | Biochemistry
![Why Are Lopinavir and Ritonavir Effective against the Newly Emerged Coronavirus 2019? Atomistic Insights into the Inhibitory Mechanisms | Biochemistry Why Are Lopinavir and Ritonavir Effective against the Newly Emerged Coronavirus 2019? Atomistic Insights into the Inhibitory Mechanisms | Biochemistry](https://pubs.acs.org/cms/10.1021/acs.biochem.0c00160/asset/images/large/bi0c00160_0009.jpeg)
Why Are Lopinavir and Ritonavir Effective against the Newly Emerged Coronavirus 2019? Atomistic Insights into the Inhibitory Mechanisms | Biochemistry
![Core Concepts - Antiretroviral Medications and Initial Therapy - Antiretroviral Therapy - National HIV Curriculum Core Concepts - Antiretroviral Medications and Initial Therapy - Antiretroviral Therapy - National HIV Curriculum](https://cdn.hiv.uw.edu/doc/497-1/reproductive-cycle-hiv-1-sites-action-major-classes-antiretroviral-medications.jpg)